Close Menu

NEW YORK – Singaporean firms Inex Innovations and Exchange and Nova Satra Dx this week announced their merger and decision to focus on offering diagnostic testing and precision healthcare to Asian women.

The new company, called Inex Innovate, aims by next year to introduce new tests for ovarian cancer and breast cancer in Asian women. The deal is valued at $72 million and is backed by investors including Kuala Lumpur, Malaysia-based Genting, as well as Enterprise Singapore and SNS Holdings, both based in Singapore.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.